0.999

5.75% -0.061

After Hours: 1.01 0.011 +1.10%

Mainz Biomed N V (MYNZ)

Overview News Price History Why MYNZ Down? Discussions Forecast

Mainz Biomed N V stock is traded at $0.999, with a volume of 282.50K. It is down -5.75% in the last 24 hours and down -35.55% over the past month. Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Previous Close:

$1.06

Open:

$1.07

24h Volume:

282.50K

Relative Volume:

0.62

Market Cap:

$5.41M

Revenue:

$895.50K

Net Income/Loss:

$-26.30M

P/E Ratio:

-0.0152

EPS:

-65.5728

Net Cash Flow:

$-23.84M

1W Performance:

-30.14%

1M Performance:

-35.55%

6M Performance:

-52.20%

1Y Performance:

-88.24%

1-Day Range:

$0.92

$1.09

1-Week Range:

$0.92

$1.40

52-Week Range:

$0.92

$10.56

Mainz Biomed N V Stock (MYNZ) Company Profile

Name

Mainz Biomed N V

Sector

Healthcare (1129)

Industry

Diagnostics & Research (54)

Phone

Address

Employee

Twitter

Next Earnings Date

2025-09-03

Latest SEC Filings

MYNZ's Discussions on Twitter

Compare MYNZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MYNZ Mainz Biomed N V	0.999	5.74M	895.50K	-26.30M	-23.84M	-65.57
TMO Thermo Fisher Scientific Inc	587.48	215.18B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	227.39	156.94B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	725.91	55.05B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	151.25	41.12B	6.79B	1.22B	1.09B	4.2644
IQV Iqvia Holdings Inc	224.90	36.97B	15.90B	1.28B	2.21B	7.2842

Mainz Biomed N V Stock (MYNZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-25	Initiated	Maxim Group	Buy
Nov-25-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-21-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jun-21-22	Initiated	H.C. Wainwright	Buy

Mainz Biomed N V Stock (MYNZ) Latest News

07:32 AM

Will Mainz Biomed N.V. stock see insider buyingJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - newser.com

07:32 AM

04:33 AM

Is Mainz Biomed N.V. stock positioned well for digital economy2025 Bull vs Bear & Reliable Price Breakout Signals - newser.com

04:33 AM

Nov 20, 2025

Is Mainz Biomed N.V. (4TO) stock attractive for dividend growth - newser.com

Nov 20, 2025

What’s the recovery path for long term holders of Mainz Biomed N.V.Earnings Growth Report & Stepwise Swing Trade Plans - newser.com

Nov 20, 2025

Can Mainz Biomed N.V. stock continue upward trend2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com

Nov 20, 2025

Nov 19, 2025

What margin trends mean for Mainz Biomed N.V. stockJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com

Nov 19, 2025

Why Mainz Biomed N.V. (4TO) stock attracts wealthy investorsJuly 2025 Fed Impact & High Accuracy Investment Signals - newser.com

Nov 19, 2025

Is a relief rally coming for Mainz Biomed N.V. holdersInflation Watch & Verified Technical Signals - newser.com

Nov 19, 2025

Will Mainz Biomed N.V. outperform the marketBond Market & Short-Term Trading Opportunity Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

How Mainz Biomed N.V. (4TO) stock performs in easing cycles - newser.com

Nov 18, 2025

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America - The Manila Times

Nov 18, 2025

Mainz Biomed (NASDAQ: MYNZ) signs ColoAlert MOU for Peru, Colombia and Ecuador - Stock Titan

Nov 18, 2025

Nov 17, 2025

Can Mainz Biomed N.V. stock deliver strong Q4 earnings2025 Key Lessons & Breakout Confirmation Alerts - newser.com

Nov 17, 2025